or
forgot password
  • cancer clinical trials in richmond, VA

  • Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
    Hunter Holmes McGuire Veteran Affairs Medical Center
    Richmond, Virginia 23249
    Nosocomial Bacteremia, MRSA Colonization, MRSA Infection, VRE Colonization, VRE Infection
    Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Endometrial Cancer, Precancerous Condition
    IGIV Study for Chronic ITP Patients Ages 3-70
    MCV Hospital
    Richmond, Virginia 23298
    Idiopathic Thrombocytopenic Purpura
    Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Lymphoma
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Lymphoma
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Virginia Commonwealth University
    Richmond, Virginia
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Neuroblastoma
    1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
    Virginia Commonwealth University
    Richmond, Virginia
    Unspecified Adult Solid Tumor, Protocol Specific
    Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
    Viriginia Commonwealth University, Department of Radiation Oncology
    Richmond, Virginia 23298
    Cervix Cancer
    Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
    Massey Cancer Center/Virginia Commonwealth University
    Richmond, Virginia 23298
    Melanoma, Soft Tissue Sarcoma, Parathyroid Carcinoma, Small Cell Carcinoma of the Lung, Carcinoid Tumors
    Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
    Massey Cancer Center/Virginia Commonwealth University

    Trial Locations
    Massey Cancer Center/Virginia Commonwealth University
    Hunter Holmes McGuire Veterans Administration Medical Center
    Southside Regional Medical Center
    Prostate Cancer
    A Phase 1 Study of 1-Methyl-D-tryptophan in Patients With Advanced Malignancies
    VCU Massey Cancer Center
    Richmond, Virginia 23298
    Solid Tumor
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    MBCCOP, Virginia Commonwealth University

    Trial Locations
    MBCCOP, Virginia Commonwealth University
    VCU Massey Cancer Center at Stony Point
    Breast Cancer
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Richmond, Virginia 23249
    Human Immunodeficiency Virus
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Richmond, Virginia 23249
    Kidney Neoplasms
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Virginia Commonwealth University

    Trial Locations
    Virginia Commonwealth University
    Hunter Holmes McGuire Veterans Administration Medical Center
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
    Massey Cancer Center/Virginia Commonwealth University
    Richmond, Virginia 23298
    Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Acute Myeloid Leukemia, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
    Massey Cancer Center / Virginia Commonwealth University
    Richmond, Virginia 23298
    Myelodysplastic Syndrome
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Renal Cell Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Virginia Commonwealth University
    Richmond, Virginia
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Carcinoma
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Virginia Commonwealth University
    Richmond, Virginia
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
    Virginia Commonwealth University

    Trial Locations
    Virginia Commonwealth University
    Virginia Commonwealth University/MCV
    Sickle Cell Disease
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Virginia Commonwealth University
    Richmond, Virginia
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
    Virginia Commonwealth University SC
    Richmond, Virginia 23284
    Leukemia
    Islet After Kidney Transplant for Type 1 Diabetes
    Virginia Commonwealth University Health System
    Richmond, Virginia 23298
    Type 1 Diabetes Mellitus
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Virginia Commonwealth University
    Richmond, Virginia
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    NMDP Southeast District - Virginia Office
    Richmond, Virginia 23229
    Healthy
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Virginia Commonwealth University
    Richmond, Virginia
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Glioblastoma Multiforme
    PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
    Pfizer Investigational Site
    Richmond, Virginia 23249
    Carcinoma, Non-small Cell
    Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Breast Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Virginia Commonwealth University
    Richmond, Virginia
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Virginia Cancer Institute

    Trial Locations
    Virginia Cancer Institute
    Virginia Commonwealth University
    Metastatic Pancreatic Cancer
    Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
    Virginia Commonwealth University/Massey Cancer Center
    Richmond, Virginia 23298
    High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma, Recurrent Salivary Gland Cancer, Salivary Gland Acinic Cell Tumor, Salivary Gland Adenocarcinoma, Salivary Gland Adenoid Cystic Carcinoma, Salivary Gland Anaplastic Carcinoma, Salivary Gland Malignant Mixed Cell Type Tumor, Salivary Gland Poorly Differentiated Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0604)
    Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital
    Richmond, Virginia 23298
    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Massey Cancer Center
    Richmond, Virginia 23298-0037
    Peripheral T-cell Lymphoma
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    Virginia Cancer Institute
    Richmond, Virginia 23230
    Breast Cancer
    Strategic Timing of Antiretroviral Treatment
    Virginia Commonwealth University
    Richmond, Virginia
    HIV Infection
    Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
    Virginia Commonwealth University General Clinical Research Center
    Richmond, Virginia 23298
    Polycystic Ovary Syndrome
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Veterans Affairs Medical Center - Richmond

    Trial Locations
    Veterans Affairs Medical Center - Richmond
    Virginia Commonwealth University Massey Cancer Center
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Virginia Commonwealth University Massey Cancer Center
    Richmond, Virginia 23298-0037
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific